• News
  • SAN DIEGO
  • BioTech

Obesity drug maker Arena books smaller 3Q loss

San Diego-based weight loss drugmaker Arena Pharmaceuticals Inc. (Nasdaq: ARNA) said Tuesday that its third-quarter loss shrank as its research and development and manufacturing costs declined.

To continue reading, subscribe now
or
log in to your account
User Response
0 UserComments

Arena Pharmaceuticals Inc.

Company Website

6166 Nancy Ridge Drive
San Diego, CA 92121

Company Trade Data

Stock Symbol Close
Change
Chg %Chg
Volume
52-Week
High Low
ARNA
4.12
  0.00  
+ 0.00%
4,806,892,000
7.97
4.05

Insider Trade Data

Date Insider Shares Type Value
07/01/2014 Lief, Jack 223,525 Sell $1,308,582
06/27/2014 Belcher, Donald D 2,473 Sell $14,467
06/27/2014 Belcher, Donald D 2,473 Exchange $13,503
06/27/2014 Belcher, Donald D 2,473 Sell $14,467
06/27/2014 Belcher, Donald D 2,473 Exchange $13,503

Arena Pharmaceuticals Inc. Executive(s):

Jack Lief

  • Chief Executive Officer, President, Chairman

Similar Companies

NAICS - 424210 - Drugs and Druggists' Sundries Merchant Wholesalers
SIC - 5122 - DRUGS, DRUG PROPRIETARIES, AND DRUGGISTS' SUNDRIES
NAICS - 541711 - Research and Development in Biotechnology
SIC - 8733 - NONCOMMERCIAL RESEARCH ORGANIZATIONS
SIC - 8731 - COMMERCIAL PHYSICAL AND BIOLOGICAL RESEARCH
Subscribe Today!